Hospital Universitario Infanta Sofía — Clinical Trial Site

32 Registered trials

11 Currently recruiting

Organisation

Hospital Universitario Infanta Sofía

Location

San Sebastian De Los Reyes, Spain

Identifier

ORG-100046434

Address

Paseo De Europa 34, 28702, Spain

Departments

#2903; Medicina interna
#3409 - Reumatología
3123: medicina interna
3409: Reumatología
Allergology
Dermatology
Endocrinology
Endocrinology and Nutrition Service
Hematología
Internal Medicine
Medical Oncology
Medicina Interna
NA
Neurología
Neurology
oncology
Reumatología
Rheumatology
Urology

Clinical trials at this site (32)

Search interface

A study to learn more about how well BAY 3018250 works and how safe it is for people with proximal deep vein thrombosis Ended

2023-503315-15-00 Thrombolysis of symptomatic proximal vein thrombosis 4 2023-12-20
A Phase 2 study (NEPTUNE-17) to evaluate efficacy and safety of GSK3858279 in DPNP. Ended

2022-502313-28-00 Diabetic Peripheral Neuropathic Pain 4 2023-12-14
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee (TRIUMPH-4) Ended

2023-503660-17-00 Overweight 5 2023-10-09
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment… Ended

2022-503110-23-00 Metabolic liver disease in HIV-infected people 6 2023-05-05
Clinical trial developed at various hospitals where each patient randomly receive in parallel groups either placebo or treatment. Nor patien… Ended

2024-519527-14-00 Allergic rhinoconjunctivitis 5 2022-06-09
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended

2024-513123-17-00 Non-infection uveitis 5 2022-01-12
Phase 3 Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Canc… Ended

2024-513167-68-00 endometrial cancer 5 2017-11-29